HHM Wealth Advisors’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-365
Closed -$8.17K 767
2023
Q3
$8.17K Hold
365
﹤0.01% 540
2023
Q2
$9.34K Hold
365
﹤0.01% 549
2023
Q1
$8.63K Hold
365
﹤0.01% 548
2022
Q4
$7.96K Hold
365
﹤0.01% 478
2022
Q3
$9K Hold
365
﹤0.01% 451
2022
Q2
$10K Hold
365
﹤0.01% 534
2022
Q1
$14K Hold
365
﹤0.01% 497
2021
Q4
$17K Hold
365
﹤0.01% 449
2021
Q3
$17K Hold
365
﹤0.01% 425
2021
Q2
$17K Hold
365
﹤0.01% 416
2021
Q1
$16K Hold
365
﹤0.01% 402
2020
Q4
$15K Hold
365
0.01% 384
2020
Q3
$14K Hold
365
0.01% 353
2020
Q2
$13K Buy
+365
New +$11.3K 0.01% 347

Other funds holding FFTY

HHM Wealth Advisors's FFTY Position: Q4 2023 in Review

HHM Wealth Advisors sold out of CapForce IBD 50 ETF (FFTY) in Q4 2023, closing a stake of 365 shares — an estimated $8.17K sold.

HHM Wealth Advisors first reported a position in FFTY in Q2 2020 and held it in 14 quarters. The position peaked at $17K in Q4 2021. 40 funds tracked by Wall St. Rank hold FFTY as of Q4 2023.

  • HHM Wealth Advisors reported no remaining CapForce IBD 50 ETF position as of Q4 2023 after selling out during the quarter.
  • HHM Wealth Advisors sold 365 CapForce IBD 50 ETF shares in Q4 2023, an estimated $8.17K.
  • HHM Wealth Advisors first reported a position in CapForce IBD 50 ETF in Q2 2020 and held it in 14 quarters.
  • HHM Wealth Advisors's CapForce IBD 50 ETF position peaked at $17K in Q4 2021.
  • 40 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q4 2023.

Based on HHM Wealth Advisors's 13F filing for Q4 2023, filed 5 Feb 2024.